"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
Kalbitor Patient Information including How Should I Take
In this Article
- What is ecallantide (Kalbitor)?
- What are the possible side effects of ecallantide (Kalbitor)?
- What is the most important information I should know about ecallantide (Kalbitor)?
- What should I discuss with my health care provider before receiving ecallantide (Kalbitor)?
- How is ecallantide given (Kalbitor)?
- What happens if I miss a dose (Kalbitor)?
- What happens if I overdose (Kalbitor)?
- What should I avoid after receiving ecallantide (Kalbitor)?
- What other drugs will affect ecallantide (Kalbitor)?
- Where can I get more information?
What should I discuss with my health care provider before receiving ecallantide (Kalbitor)?
You should not receive ecallantide if you are allergic to it.
Before you receive ecallantide, tell your doctor if you have a history of any type of allergy.
FDA pregnancy category C. It is not known whether ecallantide will harm an unborn baby. Tell your doctor if you are pregnant.
It is not known whether ecallantide passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.
In an emergency situation, it may not be possible before you are treated with ecallantide to tell your caregivers if you are pregnant or breast-feeding. Make sure any doctor caring for your pregnancy or your baby knows you have received this medication.
How is ecallantide given (Kalbitor)?
Ecallantide is injected under the skin. You will receive this injection in a clinic or hospital setting where you can be monitored in case the medication causes serious side effects.
Ecallantide is usually given in 3 separate injections. If you still have symptoms of the angioedema attack, more injections may be given within 24 hours.
Additional Kalbitor Information
- Kalbitor Drug Interactions Center: ecallantide subq
- Kalbitor Side Effects Center
- Kalbitor Overview including Precautions
- Kalbitor FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.